BioSpace News Archive

Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company, today announced promising interim results of cohort A of its Phase 1/2a clinical trial for the treatment of patients with Amyotrophic Lateral Sclerosis (ALS).

Sept. 24, 2019 10:59 UTC Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab) Four-Week Dosing Schedule for the Adjuvant Treatment of Adult Patients with Melanoma with Involvement of Lymph Nodes or Metastatic Disease who have... Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab) Four-Week Dosing Schedule for the Adjuvant Treatment of Adult Patients with Melanoma with Involvement of Lym

Obsidian Therapeutics, a biotechnology company pioneering controllable cell and gene therapies, today announced the appointment of Erin Boyer as Vice President, Human Resources

After serving as General Counsel and Chief Operating Officer at Healthstat for the past fifteen years, the organization today announced that Warren Hutton has been named President in addition to his other roles.

Company Aims to Educate Neck and Back Pain Sufferers About Effective Treatment Option

DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the online publication of a study in The Spine Journal [1] that summarizes the results of preclinical testing for Discogenic Cells, the active ingredient in IDCT, DiscGenics’ investigational cell therapy for disc degeneration.

CarboFix has announced today that the U.S. Food and Drug Administration (FDA) has cleared its CarboClear® Carbon Fiber Fenestrated Pedicle Screw System used in the treatment of patients with advanced stage spinal tumors.

Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound disorders, today announced that Robb Knie, Chief Executive Officer, will be presenting at the Diamond Equity Research Emerging Growth Invitational in New York.

FeetMe, a medical device company that produces smart medical wearables and digital health services to improve mobility, announced it has raised € 9.4 million in Series A funding.

Neurogene Inc., a company founded with a mission to bring life-changing medicines to patients and families affected by rare neurological diseases, today announced the appointment of Christine Mikail as President